Mankind Pharma CAR-T Acquisition: Bold €48M Cancer Bet
Mankind Pharma CAR-T acquisition: a 70% stake in Armed Cell Therapeutics for €48 million. What it buys, and why the assets are still in development.
Mankind Pharma CAR-T acquisition: a 70% stake in Armed Cell Therapeutics for €48 million. What it buys, and why the assets are still in development.